Berberine chloride (TN) has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hai, L; He, Y; Li, R; Wu, J; Wu, Y | 1 |
| Duan, Y; Gu, Z; Jiang, H; Li, J; Liu, H; Sun, H; Tong, J; Wang, J; Zhang, J; Zhou, S | 1 |
2 other study(ies) available for Berberine chloride (TN) and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabetics.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Berberine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Hypoglycemic Agents; Insulin Resistance; Mice; Molecular Structure; Muscle Fibers, Skeletal; Rats; Structure-Activity Relationship | 2014 |
Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5'-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes.
Topics: AMP-Activated Protein Kinases; Animals; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line; Diabetes Mellitus, Type 2; Drug Design; Enzyme Activators; Hypoglycemic Agents; Isoquinolines; Mice; Proton Magnetic Resonance Spectroscopy; Rats; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2017 |